CANNABIS INVESTING – Cannabis News, Khiron, & Lexaria Bioscience

Financial analyst and writer of “The Cannabis Report” Ted Ohashi talks about some news affecting the cannabis world, some news that will affect Khiron (TSXV: KHRN) (OTCQX: KHRNF), and Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP). Both Khiron and Lexaria are companies in his model portfolio.

0:11 Introduction
0:48 Cannabis News
3:02 News Affecting Khiron
3:40 Lexaria Bioscience
6:25 Final Thoughts

The Cannabis Report: https://ih.advfn.com/newsletters/cannabisreport/

Khiron:

https://ih.advfn.com/stock-market/TSXV/KHRN/stock-price

https://ih.advfn.com/stock-market/USOTC/khiron-life-sciences-qx-KHRNF/stock-price

Lexaria Bioscience:

https://ih.advfn.com/stock-market/USOTC/lexaria-bioscience-qx-LXRP/stock-price

https://ih.advfn.com/stock-market/CNSX/LXX/stock-price

Website: https://investorshub.advfn.com/

Investors Hub Twitter: https://twitter.com/Investors_Hub

Talk with me on the Market Vision forum: https://investorshub.advfn.com/Investors-Hub-Market-Vision-38574/

Investors Hub LinkedIn: https://www.linkedin.com/company/investorshub-com-inc-

Investors Hub Facebook: https://www.facebook.com/InvestorsHub

Posted in Investors

3 Comments

  1. @jasonc7605 on April 11, 2024 at 8:00 am

    Would add to other cautionary comments here. Ted has proven to be a very poor analyst imo. I rarely have seen him actually discuss real valuation metrics which is a huge disservice to his followers. The EV to projected sales metric alone would have led him to issue a sell signal on Khiron when it was trading at upwards of a 500M market cap with barely 10M in annual sales. Even if he didn’t know proper valuation analysis he should have at least acknowledged the falling off a cliff setup in the chart. And I’m not even mentioning the Sunniva disaster that Ted recommended all the way down despite executive after executive jumped ship. It has begged the question of whether he is a paid pumper just posting rosy looking forecasts and interviews with ceos. Listen to his recommendations with extreme caution. Just an opinion



  2. @admik6340 on April 11, 2024 at 8:27 am

    So today Lexaria debuted on NASDAQ , if you have listen to this moron Ted and accumulated stock in last 4 weeks your avg price should be around $0.25 . Reverse split 30 old stocks for one new . Let’s do the math 30X 0.25 = $7.5 it was your cost to obtain equivalent of one new stock . First day of trading on NASDAQ share price $4.5 .You have lost 40% of your money overnight . Those of us who trusted this bastard 2 years ago and bought at $2 range… 30X2 = $60 . Todays value is $4.5 so loss of 92.5 % . STAY AWAY FROM THIS CLOWN !!!!



  3. @admik6340 on April 11, 2024 at 8:45 am

    Run away from Ted’s "advices" I lost so far more than $700K USD following him. Mostly on Sunniva , Namaste , Lexaria and others .
    This guy is wrong all the time !!!